Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

v3.8.0.1
Accrued Expenses
 3 Months Ended
Mar. 31, 2018
Accrued Expenses  
Accrued Expenses

7. Accrued Expenses

 

Accrued expenses consisted of the following (in thousands):

 

 

 

 

 

 

 

 

 

 

    

March 31, 2018

    

December 31, 2017

 

External research and preclinical development

 

$

6,682

 

$

5,875

 

Employee compensation and benefits

 

 

1,134

 

 

2,494

 

Professional fees

 

 

1,121

 

 

1,225

 

Facilities and other

 

 

43

 

 

134

 

 

 

$

8,980

 

$

9,728